Intelligent Bio Solutions (INBS) Cash from Operations (2020 - 2025)
Intelligent Bio Solutions' quarterly Cash from Operations came in at 2755388.0 in Q1 2025, down 12.62% year-on-year from 3153439.19 in Q1 2024, and down 18.52% quarter-over-quarter from 2324752.0 in Q4 2024.
Intelligent Bio Solutions has reported Cash from Operations for 6 years, with the latest figure at 2755388.0 in Q1 2025.
- For the quarter ending Q1 2025, Cash from Operations fell 12.62% year-over-year to 2755388.0; the trailing twelve-month figure through Mar 2025 stood at 9913920.0 (down 37.47% YoY), and the FY2023 full-year result was 7377378.0, down 119.69% from the prior year.
- Cash from Operations for Q1 2025 stood at 2755388.0, down from 2324752.0 in the prior quarter.
- The five-year high for Cash from Operations was 82962.0 in Q3 2021, with the low at 6159435.0 in Q1 2021.
- Average Cash from Operations over 5 years is 2042035.56, with a median of 2109243.5 recorded in 2022.
- Peak annual rise in Cash from Operations reached 103.1% in 2021, while the deepest fall reached 2717.02% in 2021.
- Tracing INBS's Cash from Operations over 5 years: stood at 1425567.0 in 2021, then sank by 67.01% to 2380850.0 in 2022, then retreated by 20.51% to 2869158.0 in 2023, then advanced by 18.97% to 2324752.0 in 2024, then decreased by 18.52% to 2755388.0 in 2025.
- The last three Cash from Operations figures came in at 2755388.0 (Q1 2025), 2324752.0 (Q4 2024), and 2387216.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.74 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 220.10 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 525.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 335.40 Mn |
| 10 | Intelligent Bio Solutions | 13.61 Mn | 12.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -2.76 Mn |
| Mar 31, 2025 | -2.76 Mn |
| Dec 31, 2024 | -2.32 Mn |
| Dec 31, 2024 | -2.32 Mn |
| Sep 30, 2024 | -2.39 Mn |
| Sep 30, 2024 | -2.39 Mn |
| Mar 31, 2024 | -2.45 Mn |
| Mar 31, 2024 | -2.45 Mn |
| Dec 31, 2023 | -2.87 Mn |
| Dec 31, 2023 | -2.87 Mn |
| Sep 30, 2023 | -1.31 Mn |
| Sep 30, 2023 | -1.31 Mn |
| Jun 30, 2023 | -584,338.00 |
| Jun 30, 2023 | -584,338.00 |
| Mar 31, 2023 | -2.52 Mn |
| Mar 31, 2023 | -2.52 Mn |
| Dec 31, 2022 | -2.38 Mn |
| Dec 31, 2022 | -2.38 Mn |
| Sep 30, 2022 | -1.89 Mn |
| Sep 30, 2022 | -1.89 Mn |
| Jun 30, 2022 | -1.72 Mn |
| Jun 30, 2022 | -1.72 Mn |
| Mar 31, 2022 | -292,224.00 |
| Mar 31, 2022 | -292,224.00 |
| Dec 31, 2021 | -1.43 Mn |
| Dec 31, 2021 | -1.43 Mn |
| Sep 30, 2021 | 82,962.00 |
| Sep 30, 2021 | 82,962.00 |
| Jun 30, 2021 | -1.68 Mn |
| Jun 30, 2021 | -1.68 Mn |
| Mar 31, 2021 | -6.16 Mn |
| Mar 31, 2021 | -6.16 Mn |
| Dec 31, 2020 | -776,967.00 |
| Dec 31, 2020 | -776,967.00 |
| Sep 30, 2020 | -2.68 Mn |
| Sep 30, 2020 | -2.68 Mn |
| Jun 30, 2020 | 194,975.00 |
| Jun 30, 2020 | 194,975.00 |
| Mar 31, 2020 | -218,651.00 |
| Mar 31, 2020 | -218,651.00 |